News

Cannabis Research: Cancer Posted on 15 Jan 13:45

Cancer is a large group of diseases, which results in uncontrolled and rapid cell growth. Due to the uncontrolled growth of the cancer cells invade the surrounding healthy tissue and destroy it. Cancer usually starts in one part of the body, but can spread through the bloodstream and lymphatic system. There are more than 200 types of cancer that occur in humans, which all have different symptoms, depending on where they are located.
Brain cancer studies:
1) Anti-tumor effects of cannabidiol, a non-psychoactive cannabinoid, on human glioma cell lines (anti-tumor effects of cannabidiol, a cannabinoid Nonpsychoactive, on Human Glioma Cell Lines - 2003)
Under laboratory conditions, research has been conducted in order to investigate the hypothesis that CBD have anti-tumor properties. It was found that CBD is the viability of the tumor cells dropped significantly, suggesting that CBD is an effective antitumor agent. Published in the "Journal of Pharmacology and Experimental Therapeutics."
2) Neuroprotection by Δ9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain induced by excitotoxicity in the living organism (Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo excitotoxicity - 2001)
This research was designed to investigate the effects of THC on acute brain damage and brain degenerative diseases. It has been found that THC has an effect that protects the brain from degenerative diseases. Published in the "Journal of Neuroscience."
3) A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme (A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme - 2006)
This study was the first that was designed to explore the antitumor properties of cannabinoids in a clinical setting. She came to positive results, and it was found that THC and other cannabinoids inhibit tumor growth in patients. Published in the "British Journal of Cancer."
4) A combined preclinical therapy of cannabinoids and temozolomide against glioma (A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma - 2011)
This research aimed to evaluate the use of THC in conjunction with the drug TMZ in the treatment of glioblastoma multiforme - the most common and very resistant form of brain cancer. It has been found that the combined treatment showed that the reversed-tumor activity. Published in the journal "Molecular Cancer Therapeutics."
Breast cancer studies:
1) Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma (anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma - 2006)
This research recognizes the antitumor effects of THC, but claims that it was problematic because of its psychoactive properties. Therefore, they went on to assess the effects of other cannabinoids. It was found that CBD showed promising anticarcinogenic characteristics that should be investigated further. Published in the "Journal of Pharmacology and Experimental Therapeutics."
2) pathways in mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion and metastasis (Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis - 2010)
This study was designed to determine the effects of CBD on breast cancer cells. It was found that it inhibited the growth and the spread of these cancer cells. It has also been discovered that CBD significantly reduced the tumor mass. Published in the "U.S. Library of Medicine."
3) Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition (Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition - 2010)
This research describes experiments that were performed to assess the effects of cannabinoids on the very aggressive ERB2-positive breast cancer. They concluded that cannabinoids both tumor growth, as well as the amount of existing tumors appeared to decrease, which strongly suggests that they represent a real application for the therapeutic treatment of breast cancer. Published in the journal "Molecular Cancer."
4) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation (The endogenous cannabinoid anandamide Inhibits human breast cancer cell proliferation - 1998)
This research was designed to investigate the effects of cannabinoids on the proliferation of breast cancer cells. It has been found to inhibit the growth. Published in the "National Academy of Sciences (PNAS)."
Lung cancer studies:
1) Δ9-Tetrahydrocannabinol inhibits both triggered by the epithelial growth factor lung cancer cell migration outside of the living organism, as well as the growth and metastasis in the living organism (Δ9-Tetrahydrocannabinol Inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo - 2008)
This research was conducted to study the effects of THC to the epithelial growth factor induced by cancer - a particularly aggressive and resistant to chemotherapy form of cancer. It was found that THC has played a significant role in inhibiting cancer growth, which justifies further research in this direction. Published in the journal "Oncogene."
2) Cannabidiol inhibits lung cancer cell invasion and metastasis via the intercellular adhesion molecule-1 (Cannabidiol Inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1-2011)
In this research, it was tried to examine the effects of CBD on the invasiveness of cancer. It has been found that cannabinoids inhibit the invasiveness of the primary tumor cells in patients with lung cancer. Published in the "U.S. National Library of Medicine."
3) The cannabinoid receptors CB1 and CB2 as new targets for the inhibition of large cell lung cancer growth and metastasis (cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis - 2011)
This research was conducted to determine the role of the cannabinoid receptor activation in lung cancer. It has been found that both inhibit the growth of cancer cells and enhance their apoptosis - the natural process of cell death. Published in the "U.S. National Library of Medicine."
Prostate cancer studies:
1) Anti-proliferative and apoptotic effects of anandamide in human Prostatakrebszellinien: implication of the reduction of epidermal growth factor receptors and ceramide production (anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production - 2003)
This study describes how the activation of cannabinoid receptors causes an antiproliferative effect in cancer cells in the prostate, which has major implications for the treatment of prostate cancer. Published in the "U.S. National Library of Medicine."
2) The role of cannabinoids in prostate cancer: basic scientific point of view and possible clinical applications (The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications - 2012)
This study conducted a multi-evaluation of many other previous research on prostate cancer to determine whether cannabinoids have a practical clinical application. It has been found that it is in everyone's best interest to conduct clinical trials of medical cannabis. Published in the "U.S. National Library of Medicine."
3) Non-THC Cannabinoids inhibit prostate cancer growth in vitro and in vivo: Pro-apoptotic effects and the underlying mechanisms (non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms - 2013)
This research was designed to extend the previously explored idea that cannabinoid receptor activation causes cell death in prostate cancer cells. The research found significant positive results and found that the data supported the clinical tests of CBD from prostate cancer patients. Published in the "U.S. National Library of Medicine."
Blood cancer studies:
1) cannabinoid receptor-mediated apoptosis induced by R (+)-methanandamide and WIN55 0.212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma (Cannabinoid Receptor-Mediated Apoptosis Induced by R (+)-Methanandamide and WIN55, 212 - 2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma - 2006)
This research was designed to explore whether cannabinoids inhibit cancer cells in lymphomas. It describes that it has been found that cannabinoids inhibit the growth and induce cell death in mantle cell lymphoma (blood cancer). Published in the journal "Molecular Pharmacology."
2) triggered by Δ9-tetrahydrocannabinol apoptosis in Jurkat T-leukemia cells is regulated by the translocation of BAD mitochondria. (Δ9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria - 2006)
This research discusses how the use of cannabinoids in apoptosis (regulated and the natural death of cells) is to be evaluated. They yielded positive results, and it was found that cannabinoids actually cause the death of carcinogenic leukemia cells. Published in the "U.S. National Library of Medicine."
3) Activation of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation (expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation - 2008)
This research aimed to determine the effects of the cannabinoid receptor activation on lymphomas. It has been found that the cannabinoid receptor activation, the multiplication and growth of lymphoma reduced, and causes the death of some cancer cells. Published in "International Journal of Cancer."
Oral cancer studies:
Cannabinoids inhibit cellular respiration of human oral cancer cells (Cannabinoids inhibit cellular respiration of human oral cancer cells - 2010)
This research was aimed to investigate the effects of cannabinoids on cell respiration in certain types of oral cancer. It has been found that cannabinoids inhibit cancer cell respiration and therefore have a toxic effect on them. This implies that cannabinoids may be used for the treatment of oral cancer. Published in the "U.S. National Library of Medicine."
Liver cancer studies:
Anti-tumor effect of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy (Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy - 2011)
This research aimed to determine what the effects of THC on cancer cells in the liver. It has been found that the growth of THC and the effectiveness of these cancer cells is reduced, which means that THC should be further examined as a therapeutic treatment. Published in the "U.S. National Library of Medicine."
Pancreatic cancer studies:
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes (Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress-Related Genes - 2006)
This study suggests that pancreatic tumor tissue seems to have a much higher number of cannabinoid receptors compared to normal pancreatic tissues. The study found that, when the cannabinoids are administered to cancer cells began to die by apoptosis, resulting in a reduction in the growth and spread of the tumor. Published in "The American Journal of Cancer."


Cannabis Research: Epilepsy Posted on 15 Jan 13:38

Cannabis Research: Epilepsy

Epilepsy
Epilepsy is a neurological disorder that causes intense bursts of electrical energy within the brain. This causes a temporary but recurring disorder, how the brain works - which leads to an epileptic seizure. An epileptic seizure can, among many other symptoms, loss of consciousness, sensory disturbances and convulsions Run.
Studies
1) cannabidiol shows antiepileptiforme properties and counteracts Krämofen; in vitro and in vivo (cannabidiol displays Antipileptiform and antiseizure Properties In Vitro and In Vivo - 2010)
This research aimed to experimentally explore the wider effects of CBD on its anticonvulsant properties in animals and in isolated tissue. It was found that CBD and its effects on the CB1 receptors showed the potential to inhibit epileptiform activity in isolated tissue samples and to reduce the severity of seizures in living animals. Published in the "U.S. National Library of Medicine."
2) Cannabidivarin has an antispasmodic effect in mice and rats (Cannabidivarin is anticonvulsant in mouse and rats - 2012)
This research was aimed to test the effect of the cannabinoid CBDV for cramps, such as those caused by epilepsy. It has been found that the use of such a cannabinoid effectively prevented convulsions and appeared to have no adverse effects on normal functions. Published in the "British Journal of Pharmacology."
3) Marijuana, Endocannabinoids and epilepsy: potentials and challenges for an improved therapeutic intervention (Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention - 2013)
This research is a meta-study, which describes that the results of many other studies show apparently that cannabinoids and marijuana potentially beneficial for those act who suffer from neurological disorders such as epilepsy. Published in the "U.S. National Library of Medicine."


Cannabis Research: gastrointestinal disorders Posted on 15 Jan 13:35

Cannabis Research: gastrointestinal disorders

gastrointestinal disorders
A gastrointestinal disorder is a disorder in which the bowel appears normal, but is not functioning properly. Common examples of such a disorder are irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) and constipation.
Studies in this area:
1) Cannabinoids and the gastrointestinal tract (gastrointestinal tract and the Cannabinoids - 2001)
This study aimed to evaluate the effect of cannabinoids on the digestive system. It was found that the activation of CB1 receptors in the endocannabinoid system inhibits the production of stomach acid, suggesting that it could be used by patients for whom too much is produced and who have irritable bowel symptoms. It has also been found that there appears to be no adverse effects or withdrawal symptoms were, which can be associated with the use of cannabinoids. Published in the journal "Good."
2) Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing (Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing - 2005)
In this study it was attempted to find the position of the cannabinoid receptors in the large intestine and to determine their function. It was found that the cannabinoid receptors are distributed throughout the colon to find and that they play a role in alleviating IBD. Published in the journal "Gastroenterology."
3) Endocannabinoids and the gastrointestinal tract (gastrointestinal tract and the endocannabinoid - 2006)
This research was designed to explore the historical use of cannabis as a medicine in the treatment of gastrointestinal problems and whether cannabis really has an effect. It was found that the endocannabinoid system serves to protect the Verdauuungssystem against anomalies, which means that cannabis may be an effective way to treat those who suffer from such diseases. Published in the "U.S. National Library of Medicine."
4) Cannabis use in patients with chronic inflammatory bowel disease (Cannabis use amongst patients with inflammatory bowel disease - 2011)
Previous studies suggest that the endocannabinoid system plays a role in preventing and protecting against inflammation in the colon. Through questionnaires, which assessed the habits of cannabis use of patients with related disorders, it was found that the use of cannabis seemed to have a positive therapeutic benefit and further research should be carried out in this direction. Published in the "U.S. National Library of Medicine."


"New York Times" calls for cannabis legalization Posted on 15 Jan 13:29

cannabis legalization

The "New York Times" is one of the most respected media outlets in the USA for the legalization of cannabis has spoken. In a sensational editorials have been for more than four decades valid prohibition with the times of Prohibition, from 1920 to 1933 is compared, were prohibited as manufacture and sale of alcohol in the United States strictly. It stated cannabis addiction bring compared to alcohol and tobacco dependence "relatively minor problems" with it.

In the editorial, the authors pointed out that pleasure-loving people would have been on drinking during Prohibition, which "law-abiding citizens have been turned into criminals and crime syndicates flourished." In addition, today were young black men, according to FBI statistics clearly bear the brunt of the result is "racist" cannabis prohibition.

According to the U.S. Federal Bureau of Investigation in 2012, there were over 650,000 arrests for possession of marijuana - much more than cocaine, heroin and related drugs. U.S. President Barack Obama had already indicated that poor youth who belong to social minorities, often for marijuana use in jail migrate as better-off peers.

Although the "New York Times" said in her - even for internal editorial controversial - contribution for a ban on the sale of marijuana to adolescents under 21 years. For healthy adults seem "moderate consumption" but to pose a risk, which is why the law adopted by Congress at the federal level more than four decades prohibition was untimely. On the website of the newspaper some readers warned against underestimating the danger of the popular "gateway drug", others called the legalization overdue.


Hemp knowledge Posted on 15 Jan 13:25

Hemp knowledge

Hashish and marijuana, the two most famous cannabis products, today the world's most consumed illegal drugs. Consumers see are usually not as addicts. Indeed a addictive nature of cannabis has been able to be clearly supported by any single scientific study.

Since prehistoric times hemp in Europe and Asia is used as a drug, remedies and fiber supplier. In the last 2000 years, the hemp widespread in Africa and has been incorporated in the culture of many indigenous tribes. After the discovery of America, hemp was by the conquerors in the New World.

The hemp could play an important role in today's medicine. So he may very well fight that occurs as a side effect of chemotherapy nausea for instance. Also in the Ayurvedic medicine and homeopathy he has found entrance.

Today, cannabis is banned almost worldwide. Objective scientific studies were not a decisive factor for the ban. Rather, it is to aspirations of the USA back in the 30s. The reasons for this were racist, power-political and economic motives. Not only possession and consumption of hemp products were criminalized by this ban, but also the cultivation. This was not only the production of medicines from cannabis illegal, but also its use as a source of fiber, which destroyed an entire industry.

Meanwhile, the use of cannabis in many countries will (again) be tolerated. The Medicinal Use of Cannabis, however, is still not legal. However, there are prescription drugs with synthetic or semi-synthetic cannabinoids, which are used in many countries. Their effect is however often experienced by consumers unpleasant than those of natural cannabis, such as hashish or marijuana.


cannabidiol (CBD) in Focus Posted on 15 Jan 13:22

cannabidiol (CBD)

This is, interestingly, not as standard practice moved as cannabis ingredient THC into the center, but the cannabidiol (CBD).
Tetrahydrocannabinol (THC) is always shown as the main active ingredient in cannabis. But cannabis contains 66 different cannabinoids with different modes of action.
For THC the therapeutic use in some situations is difficult by the intoxicating effect. In addition, do not reach all patients with a pure THC preparation - in Switzerland as dronabinol in trade - a satisfactory treatment outcome.
Unlike THC CBD developed no psychoactive “high.” effect.
On the contrary, according to recent studies, CBD should neutralize the psychoactive effect of the THC's or at least slow down. Moreover, it should also have a cancer and anti-inflammatory effect. Already known for some time was its anticonvulsant, anxiolytic, and nausea-relieving effect. In addition, CBD is only slightly toxic and has few side effects, emphasizes the pharmacist Rudolf cautery, a specialist in cannabis at the University of Bern.
For a long time the research around the use of cannabis in medicine, according to cautery has mainly focused on the active ingredient THC. Cannabinoids have been used primarily to treat neurological disorders such as multiple sclerosis or epilepsy, against the side effects of chemotherapy or for chronic pain. The discovery of the CBD and its potency of cannabis gave new impetus to international research, says branding iron. For the natural remedies cannabis thereby always open new research approaches, such as the application in breast cancer, or psychosis. Medicinalcannabis has become increasingly important in recent years.

One consequence of this cannabis research is the introduction of Sativex - a drug with a combination of THC and CBD, may contribute to relief of pain and discomfort in multiple sclerosis.


Cannabis Research: Urinary incontinence Posted on 21 Dec 08:34

Cannabis Research: Urinary incontinence

Urinary incontinence

Urinary incontinence is the loss of control of the bladder, usually due to weak muscles, inflammation or nerve damage. It is mostly related to MS or Parkinson's disease.
Studies in this area:
1) A preliminary controlled study to determine whether cannabis extracts of the whole plant to improve persistent neurogenic symptoms (A preliminary controlled study to deterministic mine Whether whole-plant cannabis extracts can Improve intractable neurogenic symptoms - 2003)
This research aimed to find out whether the use of cannabis extracts would improve symptoms of MS, such as urinary incontinence, pain and spasticity. It was found that the use of cannabis appeared to improve symptoms that would otherwise respond to any other treatments more. It was also noted that the medically undesirable psychedelic symptoms occurred, though, but they were well tolerated. Published in the "U.S. National Library of Medicine."
2) An open pilot study of cannabis extracts for bladder dysfunction in advanced multiple sclerosis (n open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis - 2004)
This study was designed to verify the personal opinions that marijuana can help alleviate symptoms of Harnwegproblemen that were caused by MS. It has been found that the use of marijuana reduced the number of incontinence episodes, and the precipitated amount. In addition, it was reported that patients tended to have less pain and spasticity and sleep improved. Published in the "Multiple Sclerosis Journal".

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.


Biochemist confirmed method from their own experience Posted on 21 Dec 08:17

Biochemist and cancer researcher Dennis Hill

cancer researcher Dennis Hill

Yes ... until I came across a video that the amazing story of the American biochemist Dennis Hill says (see below). In an interview with Ava Marie s Web TV format Spiral Up Dennis told, whose specialty was the cancer research and is, by his own cancer (aggressive, metastatic prostate cancer, stage 4). Prompted by a tip that he began after receiving his diagnosis, to investigate the prepared by Rick Simpson claims - and came across a wealth of scientific material that convinced him:

Cannabis oil kills cancer cells, regardless of the nature, characteristics, aggressiveness and location of the cancer.

On his own responsibility he opted for a self attempt to address instead of the usual allopathic and radiological methods - with resounding success. Every day a drop of oil before bedtime has meant that his tumor was gone after only three months, after six months were no more cancer cells in his body detectable.

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.


Cannabis in Western medicine Posted on 20 Dec 07:59

 

 

Cannabis in Western medicine

"For cancer patients it comes as a side effect of chemotherapy often too great nausea and vomiting. Moreover, already alone the smell of food can be unbearable, so it only with great overcoming is possible many cancer patients ever receive food. Cannabis can soothing by its anti-emetic (nausea ) Effect reduce this nausea and passing through its appetizing effect to a desired weight gain. many countries THC are now (= dronabinol)-containing preparations such as the and the U.S. coming Marinol available as prescription drugs for patients. However, many patients believe that gerauchtest Cannabis works much better, which is due to the unique combination of active ingredients in the cannabis plant. However, this application is still illegal.

Also in AIDS therapy you can make the appetizing effect of cannabis advantage. In addition to therapy, it is namely often a lack of food intake, which weakens the body additionally. In addition, cannabis can distract the patient and bring a sentiment with positive attitude. Also glaucoma in which the intraocular pressure is greatly increased, which can lead to blindness can be treated with cannabis. Without surgical intervention, alone by smoking cannabis, the intraocular pressure can be lowered to normal values. For this effect is not the psychoactive THC responsible, but that hardly psychoactive substances CBN (cannabinol) and CBD (cannabidiol). Therefore, can be a therapeutic application with low-THC hemp products. Cannabis also has ataxia (movement coordinator) effect, as well as an antispasmodic, so Muscle relaxation, which makes it a good means for suppressing spasms, paralysis and convulsions, as they occur in multiple sclerosis. It can not cure the disease, but suppress the symptoms of the disease and facilitate the patient as his life. Asthma attacks can be stopped by a few traits of a joint often. Criticism here is the damage to the lungs, which of course plays an important role in asthma attacks. Remedy is here to create an inhaler that is being developed. Even a mild antibiotic effect has an ingredient that the CBD. Further acting antiepileptic cannabis, thereby epileptics while cannabis administration, the dose of medication can be reduced. Cannabis may also be used for the treatment of different pain, headache, migraine and menstrual cramps. Also in obstetrics Cannabis can be used as an alternative, as it can lead to an increased frequency of contraction of the uterus and hemostasis. In Africa and Asia, this application is used in folk medicine to this day.

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.


Shocking result: Woman replaces 40 drugs by raw cannabis juice Posted on 20 Dec 07:45

Woman replaces 40 drugs by raw cannabis juice

raw cannabis juice

Although this result might not work for all is shocking, as many people on this planet are just feeling restricted, the cannabis to offer in terms of the enormous medical benefits. A recent study, which was conducted by the Institute of Molecular Psychiatry, University of Bonn in Germany, found that that the brain cannabinoitsches system triggers the release of antioxidants, which are active as a cleaning mechanism. This process is known to remove damaged cells and the efficiency of mitochondria to improve. mitochondria are the sources supply the cells with energy. The study was published in The Phlosophical transcations of The Royal Society.

There is also a large amount of evidence that support the Tatasche that cannabis causes also an effective treatment with the potential to cure cancer. We have published a list that contains 20 medical studies showing cannabis can cure cancer (2). We already know that prescription medication each year more than 100,000 people to kill and that a herbal diet death by more than 60% of chronic diseases can be prevented. It is about time that the stigma of cannabis stops. The only reason why there is a negative image about cannabis, the fact is that this plant multiple industries (including pharmaceuticals) threatened. Cannabis together with hemp has over 50,000 applications and can help to change the world.

When cannabinoids has verified that they have reduced cancer cells and also a great influence on the strengthening of the immune system (2). While not every variety (breeding) of cannabis have the same effects, notice more and more patients within a short time a success in the reduction of cancer if they use cannabis. Contrary to popular belief and thinking of smoking of cannabis no great supportive effect in the treatment of diseases, since a therapeutic level by smoking can not be achieved. Oil of this plant or eating the plant itself is the best way around the body with the necessary cannabinoids supply.

Another aspect of smoking cannabis which must be considered is the fact that the heating and combustion of the chemical structure and acidity of the THC varies the therapeutic effect. Furthermore, one creates every time you burn something and inhaled oxidation in the body. This oxidation is not healthy for the body and can even cause health problems. This is also the reason why antioxidants are an important part of a healing diet.

 

 

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.